메뉴 건너뛰기




Volumn 64, Issue 5, 2007, Pages 645-654

The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine

Author keywords

ABCG2; Lamivudine; Pharmacokinetics; Polymorphism

Indexed keywords

FUMITREMORGIN C; LAMIVUDINE;

EID: 35248815945     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02944.x     Document Type: Article
Times cited : (51)

References (34)
  • 1
    • 1242335471 scopus 로고    scopus 로고
    • The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation
    • Haimeur A, Conseil G, Deeley RG, Cole SP. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 2004 5 : 21 53.
    • (2004) Curr Drug Metab , vol.5 , pp. 21-53
    • Haimeur, A.1    Conseil, G.2    Deeley, R.G.3    Cole, S.P.4
  • 2
    • 2142799057 scopus 로고    scopus 로고
    • Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy
    • Lockhart AC, Tirona RG, Kim RB. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy. Mol Cancer Ther 2003 2 : 685 98.
    • (2003) Mol Cancer Ther , vol.2 , pp. 685-98
    • Lockhart, A.C.1    Tirona, R.G.2    Kim, R.B.3
  • 3
    • 0037988709 scopus 로고    scopus 로고
    • Pharmacogenomics of ABC transporters and its role in cancer chemotherapy
    • Sparreboom A, Danesi R, Ando Y, Chan J, Figg WD. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. Drug Resist Updat 2003 6 : 71 84.
    • (2003) Drug Resist Updat , vol.6 , pp. 71-84
    • Sparreboom, A.1    Danesi, R.2    Ando, Y.3    Chan, J.4    Figg, W.D.5
  • 4
    • 25844443754 scopus 로고    scopus 로고
    • Breast cancer resistance protein: Molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics
    • Sugimoto Y, Tsukahara S, Ishikawa E, Mitsuhashi J. Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics. Cancer Sci 2005 96 : 457 65.
    • (2005) Cancer Sci , vol.96 , pp. 457-65
    • Sugimoto, Y.1    Tsukahara, S.2    Ishikawa, E.3    Mitsuhashi, J.4
  • 5
    • 0001744641 scopus 로고    scopus 로고
    • Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2)
    • Allen JD, Schinkel AH. Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2). Mol Cancer Ther 2002 1 : 427 34.
    • (2002) Mol Cancer Ther , vol.1 , pp. 427-34
    • Allen, J.D.1    Schinkel, A.H.2
  • 6
    • 0032404092 scopus 로고    scopus 로고
    • A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
    • Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 1998 58 : 5337 9.
    • (1998) Cancer Res , vol.58 , pp. 5337-9
    • Allikmets, R.1    Schriml, L.M.2    Hutchinson, A.3    Romano-Spica, V.4    Dean, M.5
  • 8
    • 0035300476 scopus 로고    scopus 로고
    • Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure
    • Komatani H, Kotani H, Hara Y, Nakagawa R, Matsumoto M, Arakawa H, Nishimura S. Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure. Cancer Res 2001 61 : 2827 32.
    • (2001) Cancer Res , vol.61 , pp. 2827-32
    • Komatani, H.1    Kotani, H.2    Hara, Y.3    Nakagawa, R.4    Matsumoto, M.5    Arakawa, H.6    Nishimura, S.7
  • 11
    • 0036732010 scopus 로고    scopus 로고
    • Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance
    • Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res 2002 62 : 5035 40.
    • (2002) Cancer Res , vol.62 , pp. 5035-40
    • Volk, E.L.1    Farley, K.M.2    Wu, Y.3    Li, F.4    Robey, R.W.5    Schneider, E.6
  • 12
    • 0037218382 scopus 로고    scopus 로고
    • Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors
    • Wang X, Furukawa T, Nitanda T, Okamoto M, Sugimoto Y, Akiyama S, Baba M. Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. Mol Pharmacol 2003 63 : 65 72.
    • (2003) Mol Pharmacol , vol.63 , pp. 65-72
    • Wang, X.1    Furukawa, T.2    Nitanda, T.3    Okamoto, M.4    Sugimoto, Y.5    Akiyama, S.6    Baba, M.7
  • 13
    • 4444383451 scopus 로고    scopus 로고
    • Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein
    • Wang X, Nitanda T, Shi M, Okamoto M, Furukawa T, Sugimoto Y, Akiyama S, Baba M. Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein. Biochem Pharmacol 2004 68 : 1363 70.
    • (2004) Biochem Pharmacol , vol.68 , pp. 1363-70
    • Wang, X.1    Nitanda, T.2    Shi, M.3    Okamoto, M.4    Furukawa, T.5    Sugimoto, Y.6    Akiyama, S.7    Baba, M.8
  • 14
    • 0036598543 scopus 로고    scopus 로고
    • C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance
    • Imai Y, Nakane M, Kage K, Tsukahara S, Ishikawa E, Tsuruo T, Miki Y, Sugimoto Y. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol Cancer Ther 2002 1 : 611 6.
    • (2002) Mol Cancer Ther , vol.1 , pp. 611-6
    • Imai, Y.1    Nakane, M.2    Kage, K.3    Tsukahara, S.4    Ishikawa, E.5    Tsuruo, T.6    Miki, Y.7    Sugimoto, Y.8
  • 15
    • 1242319383 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2
    • Mizuarai S, Aozasa N, Kotani H. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2. Int J Cancer 2004 109 : 238 46.
    • (2004) Int J Cancer , vol.109 , pp. 238-46
    • Mizuarai, S.1    Aozasa, N.2    Kotani, H.3
  • 19
    • 35248839749 scopus 로고    scopus 로고
    • Epivir Prescribing Information. Available at URL. Last accessed
    • Epivir Prescribing Information. Available at URL. http://us.gsk.com/ products/assets/us_epivir.pdf Last accessed 2 January 2005.
    • (2005)
  • 21
    • 0036592531 scopus 로고    scopus 로고
    • Update on the management of chronic hepatitis B
    • Davis GL. Update on the management of chronic hepatitis B. Rev Gastroenterol Disord 2002 2 : 106 15.
    • (2002) Rev Gastroenterol Disord , vol.2 , pp. 106-15
    • Davis, G.L.1
  • 22
    • 0035949821 scopus 로고    scopus 로고
    • High-performance liquid chromatographic assay for the determination of 2′-deoxy-3′-thiacytidine (lamivudine) in human plasma
    • Zheng JJ, Wu ST, Emm TA. High-performance liquid chromatographic assay for the determination of 2′-deoxy-3′-thiacytidine (lamivudine) in human plasma. J Chromatogr B Biomed Sci Appl 2001 761 : 195 201.
    • (2001) J Chromatogr B Biomed Sci Appl , vol.761 , pp. 195-201
    • Zheng, J.J.1    Wu, S.T.2    Emm, T.A.3
  • 24
    • 0035125214 scopus 로고    scopus 로고
    • Uptake properties of lamivudine (3TC) by a continuous renal epithelial cell line
    • Leung S, Bendayan R. Uptake properties of lamivudine (3TC) by a continuous renal epithelial cell line. Can J Physiol Pharmacol 2001 79 : 59 66.
    • (2001) Can J Physiol Pharmacol , vol.79 , pp. 59-66
    • Leung, S.1    Bendayan, R.2
  • 25
  • 26
    • 0033849375 scopus 로고    scopus 로고
    • Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs
    • Wada S, Tsuda M, Sekine T, Cha SH, Kimura M, Kanai Y, Endou H. Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. J Pharmacol Exp Ther 2000 294 : 844 9.
    • (2000) J Pharmacol Exp Ther , vol.294 , pp. 844-9
    • Wada, S.1    Tsuda, M.2    Sekine, T.3    Cha, S.H.4    Kimura, M.5    Kanai, Y.6    Endou, H.7
  • 28
    • 0037110745 scopus 로고    scopus 로고
    • Impaired 2′,3′-dideoxy-3′-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11
    • Turriziani O, Schuetz JD, Focher F, Scagnolari C, Sampath J, Adachi M, Bambacioni F, Riva E, Antonelli G. Impaired 2′,3′-dideoxy-3′- thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11. Biochem J 2002 368 : 325 32.
    • (2002) Biochem J , vol.368 , pp. 325-32
    • Turriziani, O.1    Schuetz, J.D.2    Focher, F.3    Scagnolari, C.4    Sampath, J.5    Adachi, M.6    Bambacioni, F.7    Riva, E.8    Antonelli, G.9
  • 31
    • 0038265441 scopus 로고    scopus 로고
    • ABCG2 transports sulfated conjugates of steroids and xenobiotics
    • Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y. ABCG2 transports sulfated conjugates of steroids and xenobiotics. J Biol Chem 2003 278 : 22644 9.
    • (2003) J Biol Chem , vol.278 , pp. 22644-9
    • Suzuki, M.1    Suzuki, H.2    Sugimoto, Y.3    Sugiyama, Y.4
  • 32
    • 0141815941 scopus 로고    scopus 로고
    • Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter
    • Volk EL, Schneider E. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res 2003 63 : 5538 43.
    • (2003) Cancer Res , vol.63 , pp. 5538-43
    • Volk, E.L.1    Schneider, E.2
  • 33
    • 33745929357 scopus 로고    scopus 로고
    • Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: A pilot study
    • Anderson PL, Lamba J, Aquilante CL, Schuetz E, Fletcher CV. Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study. J Acquir Immune Defic Syndr 2006 42 : 441 9.
    • (2006) J Acquir Immune Defic Syndr , vol.42 , pp. 441-9
    • Anderson, P.L.1    Lamba, J.2    Aquilante, C.L.3    Schuetz, E.4    Fletcher, C.V.5
  • 34
    • 0342652467 scopus 로고    scopus 로고
    • Viral and cellular factors for resistance against antiretroviral agents
    • Groschel B, Cinatl J, Cinatl J Jr. Viral and cellular factors for resistance against antiretroviral agents. Intervirology 1997 40 : 400 7.
    • (1997) Intervirology , vol.40 , pp. 400-7
    • Groschel, B.1    Cinatl, J.2    Cinatl Jr., J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.